Corvus Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Feb 5, 2026
Filed with the SEC on Feb 5, 2026 and accepted by EDGAR at Feb 5, 2026, 10:29 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001104659-26-010750. Last ingested by Listed: Nov 5, 2026, 16:49 ET. Listed shows no prices and gives no investment advice.